Inspire Medical Systems

Inspire Medical Systems' mission is to address the critical unmet need in obstructive sleep apnea (OSA) treatment by providing an effective, patient-friendly alternative to CPAP. The company has achieved significant commercial success with its FDA-approved Inspire upper airway stimulation system, establishing robust clinical evidence, broad insurance coverage, and a scalable commercial infrastructure in the United States. Its strategy centers on deepening market penetration through surgeon education, expanding clinical indications, and leveraging its first-mover advantage in a high-growth neuromodulation segment of the sleep apnea market.

A proprietary, responsive upper airway stimulation (UAS) platform featuring an implantable pulse generator, a sensing lead that monitors respiratory effort, and a stimulation lead that delivers mild electrical pulses to the hypoglossal nerve to open the airway during sleep.